NASDAQ: IRDOpus Genetics Inc Stock Ownership - Who owns Opus Genetics?
Insider buying vs selling
Have Opus Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nirav S. Jhaveri | Chief Financial Officer | 2025-02-13 | 8,207 | $1.15 | $9.44kSell |
| Ashwath Jayagopal | Chief Scientific Dev. Ofc. | 2025-02-13 | 5,193 | $1.15 | $5.97kSell |
| Bernhard Hoffmann | SVP of Corp. Dev. | 2025-02-04 | 6,751 | $1.14 | $7.70kSell |
| Rabourn Amy Zaremba | SVP of Finance | 2025-02-04 | 8,190 | $1.14 | $9.34kSell |
| George Magrath | Chief Executive Officer | 2024-12-26 | 100,000 | $0.98 | $97.60kBuy |
| Benjamin R. Yerxa | President | 2024-11-21 | 10,000 | $0.98 | $9.83kBuy |
| George Magrath | Chief Executive Officer | 2024-11-18 | 9,706 | $1.02 | $9.94kBuy |
| George Magrath | Chief Executive Officer | 2024-11-15 | 90,294 | $1.01 | $91.20kBuy |
| George Magrath | Chief Executive Officer | 2024-11-01 | 37,050 | $1.18 | $43.72kSell |
IRD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IRD insiders and whales buy or sell their stock.
IRD Shareholders
What type of owners hold Opus Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sungkee Chung | 274.55% | 163,800,000 | $163.80M | Insider |
| Sung Sook Park | 117.66% | 70,200,000 | $70.20M | Insider |
| Frank Ferraro | 43.58% | 26,000,000 | $26.00M | Insider |
| Inok Ahn | 23.47% | 14,000,000 | $14.00M | Insider |
| Chang Ho Ahn | 19.29% | 11,510,000 | $11.51M | Insider |
| Foundation Fighting Blindness Retinal Degeneration Fund | 15.91% | 9,492,171 | $9.49M | Insider |
| Rexgene Biotech Co Ltd | 9.23% | 5,505,956 | $5.51M | Insider |
| Perceptive Advisors LLC | 7.25% | 4,325,000 | $4.33M | Institution |
| Nantahala Capital Management LLC | 5.29% | 3,157,895 | $3.16M | Institution |
| Young Soon Park | 4.54% | 2,706,500 | $2.71M | Insider |
IRD vs Biotech Stocks
Opus Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.